HNGE vs MANE
Hinge Health, Inc. vs Veradermics, Incorporated — AI-powered side-by-side comparison
HNGE
Hinge Health, Inc.
64
Buy
VS
MANE
Veradermics, Incorporated
67
Buy
| Metric | HNGE | MANE |
|---|
| AI Score |
64
|
67
|
| Price |
$87.43
|
$111.00
|
| P/E Ratio |
64.10×
|
-69.90×
|
| ROE |
-139.6%
|
57.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
84.5%
|
0.0%
|
| Debt / Equity |
0.02×
|
0.00×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
59.5
|
48.6
|
| Beta |
1.285
|
1.3492
|
| Expected Upside |
—
|
+6.7%
|
AI Committee View
Current Innellis committee reasoning for HNGE versus MANE.
MANE leads by 3 points.
MANE scores 67/100 (Buy) versus HNGE at 64/100 (Buy).
HNGE Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Price-to-book of 9.7x prices in significant intangible value — Value
- ROE of only -138.7% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 29.0% signals elevated volatility — Risk
MANE Committee View
80% agreement
5 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical